sunovion.comSunovion | Sunovion – Home Page

 -- Sunovion -- Media Contact Us Sumitomo Dainippon Pharma ENGLISH US ENGLISH EUROPE ENGLISH CANADA ENGLISH FRENCH GLOBAL ENGLISH Sunovion ENGLISH US ENGLISH EUROPE ENGLISH CANADA ENGLISH FRENCH GLOBAL ENGLISH Home Who We Are Who We are overview Our Mission, Vision & Values Executive Leadership Our History Our People Our employees strive to make a difference in people’s lives Meet the people of Sunovion Related Content See what we're working on Learn more about our Pipeline Get our latest news View our Press Releases -- Join Us Join us overview Our career paths offer you opportunities See where your career can take you at Sunovion About Sunovion Who We Are Career Opportunities Learn more about our career opportunities -- Responsibility Responsibility overview Community Building Responsibility Hands On! Day About Sunovion Who We Are Career Opportunities Learn more about our career opportunities -- Our Therapies OUR THERAPIES OVERVIEW Our Therapies Find out more about our medications today Related Content Pipeline Learn more about our treatments for tomorrow CNS Overview See how we're treating neurological disorders -- Research & Development Research & Development overview Our Pipeline Psychiatric Disorders Overview Neurological Disorders Overview Respiratory Disorders Overview Research Grants Disclosure of Clinical Study Data Condition Focus Bipolar Disorder Related Content Meet Our Leaders Antony Loebel, MD, President and Chief Executive Officer Research Grants Independent Medical Research Grants -- Explore Partnerships Explore Partnerships Overview Our Partners -- Partnering Contact Form Our Approach to Partnership See how we're collaborating with partners Related Content Our Partners See where we're developing advanced medical therapies How We Create Value Explore the types of partnerships we're looking for -- Featured News Featured News overview Press Releases Our employees strive to make a difference in people’s lives Meet the people of Sunovion Related Content Sunovion Fast Facts Media Kit About Sunovion Who We Are -- Search -- Media Contact Us FOLLOW US ON: Close Video -- Lead the way to a healthier world by putting patients at the center of everything we do We are focused on developing innovative therapies and transforming the lives of people with serious medical conditions. Watch Video -- Sunovion Marks Ten Years Of Addressing Serious Medical Conditions That Impact The Lives Of Millions Worldwide Learn about our pipeline Our History Take On Tomorrow® -- Our Goal -- Helping people with serious medical conditions lead fulfilling lives Building on a track record of discovery, development and commercialization of important therapies, we have a robust and growing portfolio of treatments to address serious psychiatric, neurological and respiratory conditions. Explore our pipeline Our therapies Find out how we are addressing serious psychiatric conditions We are investigating novel treatments to psychiatric disorders that will help people with these conditions live better lives. Take a look at our areas of psychiatric research Discover what we're doing to investigate serious neurological conditions We are engaged in the quest for treatment paths that will improve the lives of millions impacted by neurologic conditions. Review the focus of our neurological research Explore our research in serious respiratory conditions We strive to advance the science of medicine for respiratory conditions. See where we are concentrating our respiratory research Featured News Most Recent Our people share a passion to make a difference Play Video “There’s a lot of happy people that work here.” Linda A. Senior Vice President, Chief Human Resources Officer Play Video “We are doing good in the community and doing good in the world and making people feel better.” Holly D. Senior Receptionist -- Senior Receptionist Play Video “At Sunovion, we’re empowered to create our own career path.” Michelle G. Director, Marketing -- Director, Marketing Explore a future you can believe in Keyword Location Job Location Marlborough, MA Fort Lee, NJ submit search See all of our available opportunities -- Our Commitment Supporting patient advocacy in our communities We partner with leading patient advocacy organizations and participate in a wide variety of events that help to raise awareness and support educational and research programs. Sunovion by the numbers Top 20 One of the fastest-growing among top U.S. pharmaceutical companies* 1,620 employees worldwide 30K employee volunteer hours in 8 years See how we make a difference Hands On! Learn more about Sunovion’s Annual Day of Community Service Page Sources Media Corporate Documents Join Us Sunovion Parent Company: Sumitomo Dainippon Pharma FOLLOW US ON: Terms of Use Privacy Policy and Cookie Notice Medical Disclaimer Sources SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. LUNESTA, , XOPENEX HFA, and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc. APTIOM is a registered trademark of , used under license. LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd. LONHALA is a registered trademark and is a trademark of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license. eFlow and eLete are registered trademarks of PARI Pharma GmbH. KYNMOBI and are trademarks of Sunovion Pharmaceuticals Inc. © 2020 Sunovion Pharmaceuticals Inc. All rights reserved....